数据链接：
官方服务：
资源简介：
Apparent affinity ALX148 for human Fcγ receptors.
应用场景：
创建时间：
2018-08-22
相关数据集
table1_Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?.docx
Background: Combination therapy with immune checkpoint inhibitors (ICIs) has been widely used for clinical treatment in recent years, which has a better survival benefit. However, not all patients can
NIAID Data Ecosystem100
Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules.
Maternal transport of immunoglobulin to the newborn mammal is important for immune defense during the first weeks of independent life. Receptors for the Fc portion of IgG mediate the transfer of immun
PubMed Central1992-01-15 更新50
Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: multicentre experience in a low-middle-income country
Immune checkpoint inhibitors (ICIs) are widely used in clinical practice. The primary objective of this study is to evaluate the safety and efficacy of ICIs in patients diagnosed with cancer who also
Taylor & Francis Group2025-10-03 更新20
Discovery of Small-Molecule Inhibitors of the PD-1/PD-L1 Axis That Promote PD-L1 Internalization and Degradation
Several monoclonal antibodies targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) pathway have been used successfully in anticancer immunotherapy. Inherent limitations of
NIAID Data Ecosystem60
BindingDB Entry 50018444: Progress in PD-1/PD-L1 pathway inhibitors: From biomacromolecules to small molecules.
Small molecule binding data for protein Platelet-derived growth factor receptor alpha/beta, Programmed cell death 1 ligand 1, and Programmed cell death 1 ligand 2, Uniprot P05622, P26618, Q9BQ51, Q9EP
DataCite Commons2024-04-26 更新30
